PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-AstraZeneca vaccine fails to lift euro zone gvt bonds

Mon, 23rd Nov 2020 12:11

* Euro zone periphery govt bond yields http://tmsnrt.rs/2ii2Bqr
(Updates prices, adds reference to the EU's 15-year COVID-19
recovery plan bond)

By Olga Cotaga

LONDON, Nov 23 (Reuters) - Euro zone government bonds were
little changed despite positive news on a AstraZeneca
vaccine on Monday as investors focused on the major economies
under strict lockdowns and the fact that COVID-19 cases are not
receding.

Britain’s AstraZeneca said its vaccine for the novel
coronavirus could be around 90% effective without any serious
side effects, making it the latest pharmaceutical company to
report on late stage results.

But more than 58.32 million people are reported to be
infected by the coronavirus globally and 1,385,595? have died,
according to a Reuters tally.

And many of Germany's 16 federal states favour extending a
partial shutdown meant to slow the spread of the COVID-19
pandemic.

"The covid pandemic, and associated social distancing
measures, remains front and centre on investors' minds," said
ING analysts in a note to clients. "This, combined with still
cautious central banks, would reduce euro zone rates upside."

Benchmark German 10-year Bund yields were last flat at
-0.577%, after falling to a two-week low of -0.592%.
Peripheral yields were lower, with Italian 10-year BTP yields
down 1.3 basis points at 0.583%, close to its recent
0.57% record low.

Portuguese 10-year government bond yields were flat, but at
0.031%, they were close to negative territory.

Euro zone business activity contracted this month as renewed
lockdowns forced much of the bloc's dominant service industry to
close temporarily. Investors were indifferent; yields were
little changed.

The spread between German and Italian government bond yields
-- essentially the premium Italy is paying for its
debt -- stood at 115.4 basis points, close to a two-and-a-half
year low.

ING analysts see the spread between euro zone and U.S.
government bond yields shrinking, too, given that "the current
wave is at an earlier stage in the U.S. and so we expect
pessimism to be the dominant tone in U.S. markets," they said.

The spread stood at -143 basis points, near
the half-year low touched earlier this month.

Elsewhere, the European Union hired a syndicate of banks for
the sale of a new 15-year bond as part of its 'SURE' COVID-19
recovery plan, according to a lead manager memo seen by Reuters.

The bond, labelled as a social bond, and due July 4 2035,
will be launched "in the near future, subject to market
conditions", the memo said, a phrase debt management offices
usually use a day before a sale.

Belgium raised 1.494 billion euros ($1.258 billion) in an
OLO (linear bond) auction on Monday, the Belgian debt agency
said.

Belgium's 10-year government bond yields were last steady at
-0.387%.

Credit-rating agency Moody’s is expected to review Belgium's
rating on Friday, which currently stands at Aa3.

ING said a total of 14 billion euros were expected in
issuance this week from Belgium, the Netherlands and Italy.
Rabobank estimated a total of 11 billion euros.
(Reporting by Olga Cotaga, editing by Larry King and Angus
MacSwan)

More News
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.